Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DCL000718

Drug Information
NameBenzylamine derivative
CompanyPfizer
IndicationEating disorder (bulimia) Obesity Hypertension Congestive heart failure
[ICD9: 278, 307.5, 401, 428.0   ICD10: E66, F50, I10, I11, I12, I13, I15, I50]
Phase I    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C7H9N/c8-6-7-4-2-1-3-5-7/h1-5H,6,8H2
InChIKeyWGQKYBSKWIADBV-UHFFFAOYSA-N
Canonical SMILESC1=CC=C(C=C1)CN    
CAS NumberCAS 100-46-9
PubChem Compound IDCID 7504.
ChEBI40538;
TargetNeuropeptide Y receptor type 1Antagonist[1]
Ref 1Emerging drugs for eating disorder treatment. Expert Opin Emerg Drugs. 2006 May;11(2):315-36. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543